Navigation Links
Imprimis Pharmaceuticals Inc. Announces Shift in Strategic Direction
Date:11/6/2013

formulations will allow us to reach positive cash flows from our operations before our current cash position of over $16 million is exhausted," Baum said.

"We believe in the power of the clinical interaction of one patient, one physician and one pharmacist to build new, personalized therapies that have broad market appeal," Baum said. "Our story is about how real people benefit from our drugs. Our philosophy is to bring the best of these personalized medicines to patients around the country through our spirit of innovation, our partnerships with physicians and pharmacists and our proprietary review and commercialization process. Through our relationship with many innovative physicians and pharmacists across the United States, we have built a valuable innovation network that has generated significant drug innovation and related intellectual property.  Our focus on intellectual property development, combined with our formulation development capabilities, our ability to support a project with capital, and our collaborative approach, all have resonated well with our inventor partners.  We believe that this approach provides us with advantages over other development and investment partners and will offer Imprimis continuing access to new opportunities.  We look forward to an exciting new era of innovation and value creation for our shareholders."

On December 16, 2013, Imprimis will host a shareholder event in Denver, Colorado.  This event will take place at the offices of Morrison & Foerster LLP in Denver, Colorado, and will be recorded and made available for replay by visiting the Investor Relations section of the Imprimis new corporate website at www.imprimispharma.com. Additional information about the planned shareholder event will be made available on the Imprimis corporate website.

ABOUT IMPRIMIS
'/>"/>

SOURCE Imprimis Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Imprimis Announces Key Leadership Appointments
9. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
11. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt ... interaktive PDF, verfügbar unter pharmaserialisation.com , zeigt ... sie jeweils in Kraft treten. Für ... nicht länger um das "ob", sondern darum, "wann" ...
(Date:9/19/2014)... ANGELES , Sept. 19, 2014  CytRx Corporation ... development company specializing in oncology, today announced that ... present at BioCentury,s 2014 NewsMakers in the Biotech Industry ... Eastern Time. The conference will take place at the ... . A live and archived webcast ...
(Date:9/19/2014)... , Sept. 19, 2014  PCI is pleased ... (Biotec).  Biotec is a leading provider of Clinical ... in Bridgend, Wales in ... addition significantly expands PCI,s presence in the UK/EU ... by adding packaging, storage and distribution capacity, as ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
... Dec. 29, 2010 Reportlinker.com announces that a ... catalogue: Women,s Health Diagnostic Testing ... The purpose of this TriMark Publications report is ... vitro diagnostics (IVDs) market called women,s health testing. ...
... Reportlinker.com announces that a new market research report ... The Outlook for Pharmaceuticals in Central Asia ... Outlook for Pharmaceutical Markets in Asia is a ... Intelligence. Each report provides individual and highly-detailed analysis ...
Cached Medicine Technology:Reportlinker Adds Women's Health Diagnostic Testing 2Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia 2Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia 3
(Date:9/19/2014)... According to a report from HarrisMartin ... Xarelto, named as defendants in several lawsuits filed in ... the court to dismiss those suits because the alleged ... with Philadelphia.* The cases include, for instance, Fontan v. ... Comm. Pls., Philadelphia Cty.), which was brought by a ...
(Date:9/19/2014)... -- Your brain structure could help predict how willing you ... Researchers at Yale University found those with greater volume in ... may be more likely to engage in risky behavior than ... study, funded by the U.S. National Institute on Aging, involved ... the Northeast. The researchers sought to determine how brain structure ...
(Date:9/19/2014)... 19, 2014 (HealthDay News) -- The U.S. Food and Drug ... Thursday. Trulicity is part of a class of once-a-week injectable ... type 2 diabetes. "Trulicity is a new treatment ... treatment regimens to control blood sugar levels in the overall ... of the FDA,s Office of Drug Evaluation II, said in ...
(Date:9/19/2014)... Lipitor lawsuits ( http://www.thelipitorlawsuit.com/ ) ... develop Type 2 diabetes continue to move forward in ... Court, District of South Carolina, Bernstein Liebhard LLP reports. ... 2014, discovery is underway and moving forward in the ... Inc., the manufacturer of Lipitor, has produced millions of ...
(Date:9/19/2014)... 2014 "I have difficulty putting in ... to stretching the skin around my eyes during the ... me to design a more convenient method of performing ... provides a quicker, easier, more sanitary method of putting ... this task manually, saves time and effort, and helps ...
Breaking Medicine News(10 mins):Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 3Health News:Brain Structure Might Help Predict Risky Behavior 2Health News:FDA Approves Another Weekly Injectable Drug for Type 2 Diabetes 2Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3
... trees, a polluted river and a handful of concerned citizens. ... Day Sunday, //by raising its voice on various issues that ... the brink of a challenge,' said Ravi Aggarwal of Toxics ... felling of trees in the name of development needs to ...
... nine-week programme to get children especially the eight to 12-year-olds ... success. The MEND programme, as it is called, got// underway ... is opportune, considering that 30% of children in UK are ... Nutrition, and Do-it took charge of more than 1000 children. ...
... The waiting times for patients in Canada’s hospitals has ... improvement, according to the report// released by Wait Time ... stresses the importance of timely information to patients about ... ,Most hospitals have managed to keep up the target, ...
... provides permanent protection from obesity and diabetes into adulthood could ... & Industry. ,The foods, under development at ... supplemented with leptin, the hunger hormone. Those who take the ... people who are lean by nature even though they overeat? ...
... doctors and other dignitaries pledged their organs for donation at ... and Ms Gul Panag, both former Miss India, Mrs Shyama ... the first Indian to conquer North & South poles and ... ,Another unique initiative was also taken by ...
... about building casinos in the UK have not given enough ... this week’s BMJ//. ,In March the House of Lords ... Vegas-style super casino in Manchester and build 16 other casinos ... costs and benefits of liberalised gambling in the UK, but ...
Cached Medicine News:Health News:Earth Day Celebrated With Hopes of a Greener Tomorrow 2Health News:MEND - Child Obesity Programme Records Success 2Health News:Baby Foods That Prevent Obesity and Diabetes in Adulthood to Hit the Market Soon 2Health News:Health Effects of Casinos Have Been Ignored: Experts 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: